Whither Withering? The Role of Digoxin in Patients With Heart Failure Due to Systolic Left Ventricular Dysfunction in Sinus Rhythm
- 30 June 2006
- journal article
- editorial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 12 (5) , 347-348
- https://doi.org/10.1016/j.cardfail.2006.02.006
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Digoxin Use and Digoxin Toxicity in the Post-DIG Trial EraJournal of Cardiac Failure, 2006
- What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG TrialJournal of Cardiac Failure, 2006
- Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trialEuropean Heart Journal, 2005
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Digitalis Investigation Group (DIG) trial: A stimulus for further researchAmerican Heart Journal, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997